I

Immuron Limited
D

IMRN

2.19000
USD
0.03
(1.39%)
مغلق
حجم التداول
156
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
12,482,910
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Immuron Limited

القطاع: Healthcare
الصناعة: Biotechnology
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.